Research and Markets has announced the addition of the "Acne Vulgaris Forecast in 15 Major Markets 2016-2026" report to their offering.

This report provides the current prevalent population for Acne Vulgaris across 15 Major Markets (USA, Canada, France, Germany, Russia, Italy, Spain, UK, Turkey, Poland, Australia, Japan, China, Brazil and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Acne Vulgaris have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Acne Vulgaris include:

- Underlying hormone imbalance

- Puberty

- Family history

- Skin scarring

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key comorbid conditions/Features associated with the disease

8. Methodology for quantification of patient numbers

9. Top-line prevalence for Acne Vulgaris

10. Features of Acne Vulgaris patients

11. Predominant Features of Acne Vulgaris

12. Comorbid Conditions and Features of Acne Vulgaris

13. Scarring in Patients with Acne Vulgaris

14. Location of Acne

15. Patient-Based Offering

16. Online Pricing Data and Platforms

17. References

18. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/gxvz4p/acne_vulgaris